TECHNESCAN HDP POWDER FOR INJECTION 3.15 MG/VIAL [SIN10712P]
Active ingredients: TECHNESCAN HDP POWDER FOR INJECTION 3.15 MG/VIAL
Last updated 24 April 2026
Product Info
TECHNESCAN HDP POWDER FOR INJECTION 3.15 MG/VIAL
[SIN10712P]
Product information
Active Ingredient and Strength | OXIDRONATE SODIUM - 3.15 MG/VIAL |
Dosage Form | INJECTION, POWDER, FOR SOLUTION |
Manufacturer and Country | CURIUM US LLC - UNITED STATES |
Registration Number | SIN10712P |
Licence Holder | QT INSTRUMENTS (S) PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | NA |
Prescription-only Medicines with Exemptions for Supply without Prescription | NA |
Indication
INDICATIONS AND USAGE
Technescan HDP Tc 99m is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients.
Dosing
DOSAGE AND ADMINISTRATION
General Instructions
The recommended adult dose of Technetium Tc 99m-labeled Technescan HDP is 555 MBq (15 mCi) with a range of 370 to 740 MBq (10 to 20 mCi). The recommended pediatric dose is 7.4 MBq (0.20 mCi)/kg with a range of 7.4 to 13 MBq (0.20 to 0.35 mCi)/kg. The recommended minimum total pediatric dose is 37 MBq (1.0 mCi).
The maximum total dose injected into a pediatric or adult patient is 740 MBq (20.0 mCi). The maximum dose of oxidronate sodium should not exceed 2 mg.
Unit dose preparation instructions should be followed for pediatric patients. The radioactivity of each dose should be measured by a suitable radiation calibration system just prior to administration. The dose should be given intravenously by slow injection. For optimal results imaging should be performed 1 to 4 hours post-injection.
Contraindications
CONTRAINDICATIONS
None known.